BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Israeli Medtech Startup Raises $8 Million February 8, 2017 SQI Diagnostics Partners With McMaster University To Co-Develop "Instant Immunoassay" Testing Technology July 23, 2017 Flushed With Cash, Shanghai Pharma Hunts for M&A in the U.S. and Europe January 23, 2018
SQI Diagnostics Partners With McMaster University To Co-Develop "Instant Immunoassay" Testing Technology July 23, 2017
